Current role
Biotechnology · Healthcare
Board Member
2024-01-01–present
Mikael Dolsten
Board Member
Rocket Pharmaceuticals, Inc. (RCKT)Equibles does not estimate personal net worth.
About Mikael Dolsten
Mikael Dolsten is recorded as Board Member at Rocket Pharmaceuticals, Inc. (RCKT) since January 1, 2024. The newest filing on record that lists Mikael Dolsten as Board Member at Rocket Pharmaceuticals, Inc. (RCKT) is dated April 6, 2026. Rocket Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rocket Pharmaceuticals, Inc. includes Gaurav Shah (CEO and Board Member), Aaron Ondrey (CFO), Carlos Garcia-Parada (CFO) and 7 others.
Affiliation history
-
Current
2024-01-01–present
Last confirmed April 6, 2026
Company network
Leadership on record at Rocket Pharmaceuticals, Inc.
- Gaurav Shah CEO, Board Member
- Aaron Ondrey CFO
- Carlos Garcia-Parada CFO
- John Militello CFO
- Chris Stevens COO
- Christopher Stevens COO
- Martin Wilson General Counsel
- Joseph Manhede Chief Accounting Officer
- Carsten Boess Board Member
- David P. Southwell Board Member
Recent activity
No call appearances or filed executive changes recorded yet.